key: cord-0800432-0oqn4wig
authors: Zheng, Shou‐Yan; Wang, Li‐Li; Ren, Luo; Luo, Jian; Liao, Wei; Liu, En‐Mei
title: Epidemiological analysis and follow‐up of human rhinovirus infection in children with asthma exacerbation
date: 2017-10-27
journal: J Med Virol
DOI: 10.1002/jmv.24850
sha: 7b6a34f213f3dac7b1af39d410e453e24f74d5d2
doc_id: 800432
cord_uid: 0oqn4wig

To determine the prevalence of human rhinovirus (HRV) infection in children with acute asthma exacerbations, investigation of HRV viral load and severity of asthma exacerbations is also required. Nasopharyngeal aspirates and swabs were collected and assessed for respiratory viruses. HRV‐positive samples were sequenced to identify types and determine viral load. Outpatients with asthma exacerbations underwent follow‐up evaluations, their swabs were collected and clinical outcomes were recorded at their next clinic visit 4 weeks later. One hundred forty‐three inpatients and 131 outpatients, including 88 patients with asthma exacerbations and 43 controls with stable asthma were recruited. HRV‐A was mainly detected in September and February (45.5% and 33.3%, respectively), while HRV‐C was mainly detected in November and April (70.0% and 55.6%, respectively). HRV‐C was the primary type and was primarily found in inpatients with severe asthma exacerbations. HRV‐A viral load in the group of inpatients with severe exacerbations was higher than in the mild and moderate groups (P < 0.001 and P = 0.022). The HRV‐A viral load of both inpatients and outpatients was higher than that of HRV‐C (P < 0.001 and P = 0.036). The main genotypes were HRV‐C53 and HRV‐A20 among inpatients, and this genotype caused more severe clinical manifestations. HRV persisted for no more than 4 weeks, and their symptoms or signs of disease were well‐controlled well. HRV‐C was most frequently detected in asthma exacerbations. HRV‐A with high viral load led to severe asthma exacerbations.

studies have discovered over 50 new HRV strains referred to as HRV-C. [8] [9] [10] [11] [12] [13] [14] Molecular epidemiological studies suggest that the dominant types are HRV-A and HRV-C, while HRV-B is relatively rarely detected. [12] [13] [14] HRV-C accounts for the majority of asthma attacks in children and causes more severe attacks than other HRV types and other viruses. 6, [15] [16] [17] [18] [19] In our previous study, we found that HRV infection was associated with asthma in our region. 20 Some authors have demonstrated a close correlation between the HRV viral load and the disease severity in children with lower respiratory tract infections. [21] [22] [23] However, there have been no reports on the correlation of the viral load of different HRV species with the severity of asthma exacerbations.

The objective of the present study is to determine the prevalence of HRV infection in children with acute asthma exacerbations and the virus detection after acute asthma acute attacks as well as to investigate the relationship between different HRV types, viral load and severity of acute asthma exacerbations. Nasopharyngeal aspirates (NPAs) and swabs (NPSs) were collected when the patients were admitted to our department, and clinical outcomes were recorded. We conducted a follow-up study among these outpatients with asthma exacerbations and their NPSs were collected, and clinical outcomes were recorded when they visited the clinic again after 4 weeks. This study was approved by the Ethics Committee of the Children's Hospital of Chongqing Medical University. The informed consent for participation in the study was obtained from patients or legal guardians.

The severity of asthma exacerbations at presentation was determined using a previously validated reference standard for each subject by a paediatrician and divided into mild, moderate and severe groups. 24 Asthma symptom control was assessed with the Childhood Asthma Control Test 25 and divided into well-controlled, not wellcontrolled and poorly controlled groups according to the clinical symptom score.

The 5′-NCR (non-coding region) and a partial sequence of the VP4/ VP2 region was amplified by PCR as previously described. [26] [27] [28] The PCR products were sequenced by Shanghai Majorbio Bio-Pharm Technology. The nucleotide sequences were compared with reference HRV strains obtained from GenBank for typing and to distinguish human enterovirus (HEV).

Amplification of HRV RNA by real-time fluorescence quantitative PCR (RT-PCR) was performed with the 5′-NCR primers and probe. 29 RT-PCR was performed using a TaKaRa OneStep PCR kit (Takara Biotechnology, Dalian, China).

Phylogenetic analysis of HRV-positive strains was performed as described previously using the neighbour-joining (NJ) method, 27, 30, 31 and the reliability of the tree was estimated with 1000 bootstrap replications. We performed a phylogenetic tree of the VP4/VP2 coding region and 5′-NCR using the CLUSTAL W program and MEGA 5.05 software. Sequences of reference strains were obtained from the GenBank database.

Respiratory syncytial virus types A and B (RSVA, RSVB), influenza virus A, B and C (IFVA, IFVB, IFVC), human coronaviruses (HCoV-229E, HCoV-OC43), human metapneumovirus (HMPV) and parainfluenza virus (PIV types 1-4) were screened using nested PCR assays. 32, 33 Adenovirus (ADV) was detected by means of multiplex PCR, and human bocavirus 1 (HBoV1) was screened using RT-PCR. 34 

In hospitalized children, the VP4/VP2 region was successfully amplified in 56 samples: HRV-A was identified in 35.7% of samples (20/56), HRV-B in 8.9% (5/56), and HRV-C in 55.4% (31/56). The number of HRV-C-positive cases was more than those of HRV-A and HRV-B (P = 0.037 and P < 0.001). The HRV-C detection rate in severe groups was significantly higher than that of the mild group (36.1% vs 6.5%; P = 0.004). The rates of HRV-A and HRV-B-positivity rated showed no different in the three severity groups (P = 0.596 and P = 0.731). The VP4/VP2 sequence was amplified in one outpatient, while others could not be obtained because of low amplicon yield, and 5′-NCR sequences from the remaining HRV-positive specimens were used for typing. The majority of those in the group with acute asthma exacerbations (64.3%; 9/14) was infected with an HRV-C, 21.4% (3/14 ) was infected with HRV-A, only one patient was infected with HRV-B and one was untyped ( Table 2) . Because of the small number of outpatients with HRV in the different severity groups, comparisons were not performed.

The percentage of severe acute asthma exacerbations in the HRVpositive group was higher than that of the HRV-negative group (P = 0.032), while the number of patients with fever was less than that in the HRV-negative group (P = 0.007). The white blood cell counts and neutrophil percentages were both significantly higher in the HRVpositive group (P = 0.041 and P = 0.043, respectively). The other features between the HRV-positive and HRV-negative groups had no statistically significant difference. All the clinical features between single HRV-A-positive and HRV-C-positive groups had no statistically significant difference ( Table 3 ). The percentage of familial eczema and neutrophils were significantly higher in the group of outpatients with HRV infection than in the group without HRV infection (P = 0.049 and P = 0.030, respectively). The clinical characteristics of HRV-A and HRV-C-positive outpatients showed that the percentage of allergic rhinitis in the HRV-C-positive group was significantly higher than that of the HRV-A group (P = 0.045) ( Table 4 ).

The frequency of asthma exacerbations among HRV-positive inpatients was calculated as 48.0% (12/25) in spring, 44.0% (11/25) in while HRV-C was mainly detected in November and April (70.0% and 55.6%, respectively) ( Fig. 1 ).

The genome viral load of 62 inpatients infected with HRV has been detected, and 10 cases have not been detected using the 5′-NCR primers and probe. The median age of these inpatients was 45 months, and the male to female ratio was 32:30. The genome viral load ranged from 2.2 to 2.9 × 10 7 copies/mL. However, there was no significant difference of HRV total viral load among the different severities of asthma exacerbations ( Fig. 2A) . The viral load of HRV-A in the severe group was higher than that in the mild group (mean, 2.5 × 10 5 copies/mL vs 1.7 × 10 3 copies/mL; P < 0.001) and the moderate group (mean, 2.5 × 10 5 copies/mL vs 2.1 × 10 3 copies/mL; P = 0.022) (Fig. 2B) . However, the HRV-C viral load among the three groups showed no significant difference (Fig. 2C) . Moreover, the viral loads of HRV-A and HRV-B were significantly higher than the HRV-C viral load regardless of the severity (mean, 8.5 × 10 3 copies/mL vs 2.5 × 10 2 copies/mL; P < 0.001; mean, 1.6 × 10 4 copies/mL vs 2.5 × 10 2 copies/mL; P = 0.014) (Fig. 2D) . The viral load of HRV-A was higher than HRV-C in the group with severe asthma exacerbations (mean, 2.5 × 10 5 copies/mL vs 1.6 × 10 2 copies/mL; P < 0.0001) (Fig. 2E) . Because of the small number of outpatients with HRV in the different severity groups, the comparisons between different HRV types viral load and severity of disease were excluded. Even so, the total viral load of HRV was compared. And the HRV-A total viral load was significantly higher than that of HRV-C (mean, 9.4 × 10 3 copies/mL vs 7.1 × 10 2 copies/mL; P = 0.036). HRV indicates human rhinovirus. *There were more HRV-C positive inpatients in the severe asthma exacerbation than in the mild exacerbation group (P = 0.004). HRV-A20 strains, the two predominant genotypes, followed by HRV-C21 three (5.4%), HRV-A49 three (5.4%) (Fig. 3) . The clinical characteristics of HRV-C53 and HRV-A20-positive inpatients are summarized in Table 5 , the severity of their asthma exacerbations was moderate or severe and there were five cases of dyspnea. Figure 4 shows the phylogenetic tree of outpatients based on the nucleotide sequences of the 5′-NCR, and all the HRV-positive samples were grouped into 15 genotypes. One sample was amplified by the VP4/ VP2 region and divided into HRV-C22 (Accession number: JN621242).

The distribution of outpatients' genotypes had no obvious regularity and neither HRV-C53 nor HRV-A20 was found.

All the HRV-positive outpatients with acute asthma exacerbations participated in the follow-up, and only one case was infected with RSVA within 4 weeks after first the visit. The remaining patients tested negative, and the severity of the disease was well-controlled. Another 23 patients were without HRV during the first visit, while after 4 weeks, five cases of acute asthma exacerbations appeared again and among them, four patients were infected with HRV (Table 6 ).

HRV is an important cause of both upper and lower respiratory illnesses as well as acute exacerbations of childhood asthma. In our study, HRV was the most common viral pathogen that induced asthma 

Relationship between HRV viral load and severity of asthma exacerbations among inpatients. A: HRV total viral load among the three groups shows no significant difference. B: HRV-A viral load in severe group was significantly higher than in the mild and moderate groups (P < 0.001 and P = 0.022). C: HRV-C viral load the among three groups shows no significant difference. D: HRV-A and HRV-B viral load were significantly higher than HRV-C regardless of the severity (P < 0.001 and P = 0.014). E: In the severe group, HRV-A viral load was significantly higher than HRV-C (P < 0.0001). The comparison of viral load was conducted by nonparametric Mann-Whitney U-test

Although this study only included data from 3 years, we showed both annual and seasonal variation in HRV types. The seasonal prevalence of asthma exacerbations was consistent with HRV infection and occurred mainly in autumn. Our results were similar to those presented in earlier reports, which have associated the September peak in asthma hospitalizations with rhinovirus circulation. 39, 40 Our subtropical climate was the reason for the difference.

HRV-C attracts special clinical interest because they can cause more severe illnesses, requiring hospitalization in infants and children, compared with the HRV-A or HRV-B, and are closely associated with acute asthma exacerbations. 15, 41, 42 Our study has demonstrated that the HRV-C detection rate was greater than 50% among inpatients and outpatients, which supports the hypothesis that HRV-C was to the most common cause of acute asthma attacks in children. Among inpatients, HRV-C was responsible for not only the majority of acute asthma attacks compared to other HRV species or other known viruses, but was also more frequently involved in severe asthma attacks. The phylogenetic analysis showed that HRV-C53 and HRV-A20

were the predominant strains among inpatients. The HRV-C53 genotype mainly occurred in October and November 2014, HRV-A20 occurred in September and October 2015 in Chongqing, China and caused more severe clinical manifestations. HRV-C53 was once known as HRV-Cpat10, which was provisionally assigned types (designated "pat"), and we did not find other literature reporting the relationships between asthma attacks and HRV-C53 or HRV-Cpat10. 27, 28 However, the two genotypes were not found in outpatients, and these results supported that HRV-C53 and HRV-A20

were more common in severe asthma attacks.

Some observations suggested that people with asthma might be at risk for higher viral loads and symptoms affecting their respiratory tract during HRV infection. 43 Our study confirmed that HRV-A viral load in the severe asthma exacerbations group was significantly higher than that of the mild and moderate groups, while HRV-C was not. This result indicates that HRV-A viral load is associated with the severity of asthma exacerbations but HRV-C is not. Additionally, in severe asthma exacerbations, the HRV-A viral load was higher than that of HRV-C, which suggested that the mechanisms of the exacerbations were not similar.

We further compared clinical features between single HRV-A positive and HRV-C positive inpatients and no difference was found between the two groups. However, the number of outpatients with allergic rhinitis increased in the HRV-C infection group and whether indicated those asthmatic children who complicated with allergic rhinitis were tend to infect HRV-C even appear exacerbations. The findings highlight the fact that physicians and parents should provide preventive management to those children during the peak season of HRV-C infections.

HRV-C species do not grow in standard cell cultures used for virus isolation, which limits the research on their biological characteristics.

According to our understanding of the mechanism, it is possible that the HRV-C receptor is distinct from the intercellular adhesion molecule In summary, the virus most frequently detected in asthma exacerbations appears to be HRV, primarily HRV-C, which commonly occurs in severe asthma exacerbations. HRV-A with high viral load leads to severe asthma exacerbations, and HRV-C viral load and disease severity have no significant correlation. The novel genotypes HRV-C53 and HRV-A20 have been found to be predominant strains that cause more severe clinical manifestations. Additionally, we followed up on HRV changes in the airways of asthmatic children, and HRV RNA was found to persist for no longer than 4 weeks. Overall, our results provide some theoretical evidence for the prevention of childhood asthma exacerbations and improving asthma management. 

The authors have no conflicts of interest to declare.

Lower respiratory viral illnesses: improved diagnosis by molecular methods and clinical impact

Impact of respiratory virus infections on persons with chronic underlying conditions

Community study of role of viral infections in exacerbations of asthma in 9-11 year old children

Innate immunity in the pathogenesis of virus induced asthma exacerbations

Updates in the relationship between human rhinovirus and asthma

Rhinoviruses significantly affect day-to-day respiratory symptoms of children with asthma

A cytopathogenic agent isolated from naval recruits with mild respiratory illnesses

MassTag polymerase-chainreaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during

Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution

Weekly monitoring of children with asthma for infections and illness during common cold seasons

Molecular epidemiological study of human rhinovirus species A, B and C from patients with acute respiratory illnesses in Japan

Genetic analysis of the VP4/VP2 coding region in human rhinovirus species C inpatients with acute respiratory infection in Japan

Genetic analysis of human rhinovirus species A to C detected inpatients with acute respiratory infection in Kumamoto prefecture

Association between human rhinovirus C and severity of acute asthma in children

Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children

A recently identified rhinovirus genotype is associated with severe respiratory-tract infection in children in Germany

Patient characteristics and severity of human rhinovirus infections in children

Human rhinovirus C: age, season, and lower respiratory illness over the past 3 decades

Impact of human rhinovirus types and viral load on the severity of illness in hospitalized children with lower respiratory tract infections

Genetic diversity and molecular epidemiology of human rhinoviruses in South Africa. Influenza Other Respir Viruses

Rhinovirus load and disease severity in children with lower respiratory tract infections

Impact of rhinovirus nasopharyngeal viral load and viremia on severity of respiratory infections in children

Effect of nebulized ipratropium on the hospitalization rates of children with asthma

The Childhood Asthma Control Test: retrospective determination and clinical validation of a cut point to identify children with very poorly controlled asthma

Assay for 5′ noncoding region analysis of all human rhinovirus prototype strains

Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types

Proposals for the classification of human rhinovirus species C into genotypically assigned types

Use of an improved quantitative polymerase chain reaction assay to determine differences in human rhinovirus viral loads in different populations

A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences

The neighbor-joining method: a new method for reconstructing phylogenetic trees

Simultaneous detection of fourteen respiratory viruses in clinical specimens by two multiplex reverse transcription nested-PCR assays

Simultaneous detection of influenza A, B, and C viruses, respiratory syncytial virus, and adenoviruses in clinical samples by multiplex reverse transcription nested-PCR assay

Species-specific identification of human adenoviruses by a multiplex PCR assay

Human bocavirus and acute wheezing in children

Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma

Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production

Rhinovirus-16 colds in healthy and in asthmatic subjects: similar chages in upper and lower airways

The September epidemic of asthma exacerbations in children: a search for etiology

Understanding the September asthma epidemic

Human rhinovirus C associated with wheezing in hospitalized children in the Middle East

Respiratory outcome of prematurely born infants following human rhinovirus A and C infections

Comparison of viral load in individuals with and without asthma during infections with rhinovirus

The major human rhinovirus receptor is ICAM-1

Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus

Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication

A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations

Effects of rhinovirus species on viral replication and cytokine production

Duration of rhinovirus shedding in the upper respiratory tract in the first year of life

Epidemiological analysis and follow-up of human rhinovirus infection in children with asthma exacerbation